The Organ Donation and Transplantation in Canada System Progress Report 2006–2015, developed collaboratively with Canadian Blood Services organ donation and transplantation advisory committees, provides the most current available national data on deceased and living donation and transplantation performance in Canada. The report presents an overview of the state of the country’s donation and transplantation system today.
The BloodTechNet program was launched in 2011 to facilitate the development of innovative educational resources that support the Transfusion, Cellular Therapy and Transplantation communities in Canada.
Canadian Blood Services and Trillium Gift of Life Network worked in collaboration with the Critical Care Canada Forum (CCCF) to host the Deceased Organ Donation Symposium that took place in October, 2015 in Toronto. The program reviewed current clinical practices and advances in the science of organ donation medicine, including emerging topics and evolving research. Videos of the seminars were recorded to provide those unable to attend an opportunity to meet Canadian and international critical care experts in the field of deceased organ donation.
March 24, 2017 | 8:00AM to March 25, 2017 | 5:00PM
The World Marrow Donor Association (WMDA) Spring meeting 2017 is held prior to the European Society for Blood and Marrow Transplantation (EBMT) in Marseille, France.This meeting is scheduled to take place on Friday and Saturday March 24 and 25, 2017.
Click here for more the meeting schedule and more information.
Dr. Hume, a professor at the University of Montreal and former executive medical director for Canadian Blood Services, works six months every year as a pediatric hematologist at the Mulago National Referral Hospital in Uganda.
A searchable database showcasing our funded research projects has just been launched on blood.ca. Together with our publications database, research highlights, links to this blog, research units and other news, you’ll discover a comprehensive knowledge hub for the transfusion and transplantation community.
A previous post in our "The things we do for safety" series explores leukoreduction - or how white blood cells or leukocytes get filtered out of blood products to reduce the risk of transfusion-related reactions.